You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 1
  • Gemcitabine–carboplatin–paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients

Article metrics

Article menu
Download PDFPDF
ORIGINAL ARTICLE
Gemcitabine–carboplatin–paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients

 

Online download statistics by month:

Online download statistics by month: March 2019 to April 2024

AbstractFullPdf
Mar 20191400
Apr 20191200
May 20192301
Jun 2019800
Jul 2019500
Aug 20191003
Sep 2019200
Oct 2019400
Nov 2019800
Dec 20191000
Jan 20201200
Feb 20201002
Mar 20202200
Apr 20201400
May 20201400
Jun 2020600
Jul 20202000
Aug 2020600
Sep 2020400
Oct 20204400
Nov 20201800
Dec 20201600
Jan 20211400
Feb 20211000
Mar 20211000
Apr 2021600
May 2021303
Oct 20211000
Nov 2021600
Dec 20211200
Jan 20221600
Feb 20221800
Mar 20221001
Apr 20221200
May 20224600
Jun 20223000
Jul 20221600
Aug 20223000
Sep 20223200
Oct 20222600
Nov 20221800
Dec 20222400
Jan 20231000
Feb 20235000
Mar 20231000
Apr 2023200
May 2023800
Jun 2023600
Jul 20231000
Aug 20231400
Sep 2023600
Oct 20231100
Nov 2023400
Dec 20232600
Jan 20241200
Feb 2024600
Mar 2024600
Apr 20241700
Total829010